Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/21/16 → 6/30/21 |
Funding
- Clinical Assistance Programs, LLC (Prot #GT-201 // Prot #GT-201)
- Galera Therapeutics, Inc (Prot #GT-201 // Prot #GT-201)
Prot #GT-201: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of Intravenous GC4419 on the Incidence and Duration of Severe Oral Mucositis (OM) in Patients Receiving Post-Operative or Definitive Therapy with Sing
- Matsangou, Maria (PD/PI)
Project: Research project